BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bradley BT, Bryan A. Emerging respiratory infections: The infectious disease pathology of SARS, MERS, pandemic influenza, and Legionella. Semin Diagn Pathol 2019;36:152-9. [PMID: 31054790 DOI: 10.1053/j.semdp.2019.04.006] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 14.3] [Reference Citation Analysis]
Number Citing Articles
1 Crimi E, Benincasa G, Figueroa-Marrero N, Galdiero M, Napoli C. Epigenetic susceptibility to severe respiratory viral infections and its therapeutic implications: a narrative review. Br J Anaesth 2020;125:1002-17. [PMID: 32828489 DOI: 10.1016/j.bja.2020.06.060] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
2 Sandor AM, Sturdivant MS, Ting JPY. Influenza Virus and SARS-CoV-2 Vaccines. J Immunol 2021;206:2509-20. [PMID: 34021048 DOI: 10.4049/jimmunol.2001287] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Suvarna K, Biswas D, Pai MGJ, Acharjee A, Bankar R, Palanivel V, Salkar A, Verma A, Mukherjee A, Choudhury M, Ghantasala S, Ghosh S, Singh A, Banerjee A, Badaya A, Bihani S, Loya G, Mantri K, Burli A, Roy J, Srivastava A, Agrawal S, Shrivastav O, Shastri J, Srivastava S. Proteomics and Machine Learning Approaches Reveal a Set of Prognostic Markers for COVID-19 Severity With Drug Repurposing Potential. Front Physiol 2021;12:652799. [PMID: 33995121 DOI: 10.3389/fphys.2021.652799] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Keller KG, Reangsing C, Schneider JK. Clinical presentation and outcomes of hospitalized adults with COVID-19: A systematic review. J Adv Nurs 2020;76:3235-57. [PMID: 32881050 DOI: 10.1111/jan.14558] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
5 Zhu Z, Lian X, Su X, Wu W, Marraro GA, Zeng Y. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir Res 2020;21:224. [PMID: 32854739 DOI: 10.1186/s12931-020-01479-w] [Cited by in Crossref: 172] [Cited by in F6Publishing: 1] [Article Influence: 86.0] [Reference Citation Analysis]
6 Damiani S, Fiorentino M, De Palma A, Foschini MP, Lazzarotto T, Gabrielli L, Viale PL, Attard L, Riefolo M, D'Errico A. Pathological post-mortem findings in lungs infected with SARS-CoV-2. J Pathol 2021;253:31-40. [PMID: 32930394 DOI: 10.1002/path.5549] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
7 Jun M, Oh K, Choi C. A Gap between Relaxation of Government Quarantine Policy and Perceptions of COVID-19 among the General Public in Sports: Focusing on Vaccination Status. IJERPH 2022;19:4267. [DOI: 10.3390/ijerph19074267] [Reference Citation Analysis]
8 Zhu Z, Lian X, Su X, Wu W, Marraro GA, Zeng Y. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir Res 2020;21:224. [PMID: 32854739 DOI: 10.1186/s12931-020-01479-w] [Cited by in Crossref: 112] [Cited by in F6Publishing: 82] [Article Influence: 56.0] [Reference Citation Analysis]
9 Rizkita LD, Astuti I. The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review. J Pharm Anal 2021;11:265-71. [PMID: 33782640 DOI: 10.1016/j.jpha.2021.03.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Yu Y, Chen P. Coronavirus Disease 2019 (COVID-19) in Neonates and Children From China: A Review. Front Pediatr 2020;8:287. [PMID: 32574286 DOI: 10.3389/fped.2020.00287] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
11 Yang Y, Xiao Z, Ye K, He X, Sun B, Qin Z, Yu J, Yao J, Wu Q, Bao Z, Zhao W. SARS-CoV-2: characteristics and current advances in research. Virol J 2020;17:117. [PMID: 32727485 DOI: 10.1186/s12985-020-01369-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 14.0] [Reference Citation Analysis]
12 Bakhtazad A, Garmabi B, Joghataei MT. Neurological manifestations of coronavirus infections, before and after COVID-19: a review of animal studies. J Neurovirol 2021. [PMID: 34727365 DOI: 10.1007/s13365-021-01014-7] [Reference Citation Analysis]
13 Guan CS, Lv ZB, Li JJ, Du YN, Chen H, Cui T, Guo N, Chen BD, Xie RM. CT appearances, patterns of progression, and follow-up of COVID-19: evaluation on thin-section CT. Insights Imaging 2021;12:73. [PMID: 34110540 DOI: 10.1186/s13244-021-01019-0] [Reference Citation Analysis]
14 Verstrepen K, Baisier L, De Cauwer H. Neurological manifestations of COVID-19, SARS and MERS. Acta Neurol Belg 2020;120:1051-60. [PMID: 32562214 DOI: 10.1007/s13760-020-01412-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
15 Lobato Gómez M, Huang X, Alvarez D, He W, Baysal C, Zhu C, Armario-Najera V, Blanco Perera A, Cerda Bennasser P, Saba-Mayoral A, Sobrino-Mengual G, Vargheese A, Abranches R, Abreu IA, Balamurugan S, Bock R, Buyel JF, da Cunha NB, Daniell H, Faller R, Folgado A, Gowtham I, Häkkinen ST, Kumar S, Ramalingam SK, Lacorte C, Lomonossoff GP, Luís IM, Ma JK, McDonald KA, Murad A, Nandi S, O'Keefe B, Oksman-Caldentey KM, Parthiban S, Paul MJ, Ponndorf D, Rech E, Rodrigues JCM, Ruf S, Schillberg S, Schwestka J, Shah PS, Singh R, Stoger E, Twyman RM, Varghese IP, Vianna GR, Webster G, Wilbers RHP, Capell T, Christou P. Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases. Plant Biotechnol J 2021. [PMID: 34182608 DOI: 10.1111/pbi.13657] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Shrestha D, Ye GX, Stabley D, Betal SGN, Zhu Y, Glazewski L, Holbrook J, Sethi M, Hesek A, Shaffer TH, Aghai ZH, Addya S, Alapati D. Pulmonary immune cell transcriptome changes in double-hit model of BPD induced by chorioamnionitis and postnatal hyperoxia. Pediatr Res 2021. [PMID: 33446917 DOI: 10.1038/s41390-020-01319-z] [Reference Citation Analysis]
17 Hoang TG, Truong NT, Nguyen TM. The survival of hotels during the COVID-19 pandemic: a critical case study in Vietnam. Serv Bus 2021;15:209-29. [DOI: 10.1007/s11628-021-00441-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
18 Hadisi Z, Walsh T, Dabiri SMH, Seyfoori A, Hamdi D, Mirani B, Pagan E, Jardim A, Akbari M. Management of Coronavirus Disease 2019 (COVID-19) Pandemic: From Diagnosis to Treatment Strategies. Adv Ther (Weinh) 2020;:2000173. [PMID: 33614905 DOI: 10.1002/adtp.202000173] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Manohar P, Loh B, Nachimuthu R, Hua X, Welburn SC, Leptihn S. Secondary Bacterial Infections in Patients With Viral Pneumonia. Front Med (Lausanne) 2020;7:420. [PMID: 32850912 DOI: 10.3389/fmed.2020.00420] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
20 Chen Q, Yang X, Fang Y, Chen G, Lv X. Potential benefits of precise corticosteroid therapy for critical COVID-19. Respir Physiol Neurobiol 2021;:103813. [PMID: 34801741 DOI: 10.1016/j.resp.2021.103813] [Reference Citation Analysis]
21 Fan S, Yan S, Liu X, Liu P, Huang L, Wang S. Human Coronavirus Infections and Pregnancy. Matern Fetal Med 2021;3:53-65. [PMID: 34192279 DOI: 10.1097/FM9.0000000000000071] [Reference Citation Analysis]
22 Çakır B, Okuyan B, Şener G, Tunali-Akbay T. Investigation of beta-lactoglobulin derived bioactive peptides against SARS-CoV-2 (COVID-19): In silico analysis. Eur J Pharmacol 2021;891:173781. [PMID: 33271151 DOI: 10.1016/j.ejphar.2020.173781] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Tiwari SK, Dicks LMT, Popov IV, Karaseva A, Ermakov AM, Suvorov A, Tagg JR, Weeks R, Chikindas ML. Probiotics at War Against Viruses: What Is Missing From the Picture? Front Microbiol 2020;11:1877. [PMID: 32973697 DOI: 10.3389/fmicb.2020.01877] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
24 Tusé D, Nandi S, Mcdonald KA, Buyel JF. The Emergency Response Capacity of Plant-Based Biopharmaceutical Manufacturing-What It Is and What It Could Be. Front Plant Sci 2020;11:594019. [DOI: 10.3389/fpls.2020.594019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
25 Behzad S, Aghaghazvini L, Radmard AR, Gholamrezanezhad A. Extrapulmonary manifestations of COVID-19: Radiologic and clinical overview. Clin Imaging 2020;66:35-41. [PMID: 32425338 DOI: 10.1016/j.clinimag.2020.05.013] [Cited by in Crossref: 90] [Cited by in F6Publishing: 77] [Article Influence: 45.0] [Reference Citation Analysis]
26 Pharo EA, Williams SM, Boyd V, Sundaramoorthy V, Durr PA, Baker ML. Host-Pathogen Responses to Pandemic Influenza H1N1pdm09 in a Human Respiratory Airway Model. Viruses 2020;12:E679. [PMID: 32599823 DOI: 10.3390/v12060679] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
27 Zhao Z, Wei Y, Tao C. An enlightening role for cytokine storm in coronavirus infection. Clin Immunol 2021;222:108615. [PMID: 33203513 DOI: 10.1016/j.clim.2020.108615] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
28 Geramizadeh B, Marzban M. Histopathologic Findings of Coronavirus in Lung: A Mini-Review. Clin Pathol 2020;13:2632010X20951823. [PMID: 33111059 DOI: 10.1177/2632010X20951823] [Reference Citation Analysis]
29 Zhu S, Song W, Sun Y, Zhou Y, Kong F. MiR-342 attenuates lipopolysaccharide-induced acute lung injury via inhibiting MAPK1 expression. Clin Exp Pharmacol Physiol 2020;47:1448-54. [PMID: 32248545 DOI: 10.1111/1440-1681.13315] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
30 Teodori L, Sestili P, Madiai V, Coppari S, Fraternale D, Rocchi MBL, Ramakrishna S, Albertini MC. MicroRNAs Bioinformatics Analyses Identifying HDAC Pathway as a Putative Target for Existing Anti-COVID-19 Therapeutics. Front Pharmacol 2020;11:582003. [PMID: 33363465 DOI: 10.3389/fphar.2020.582003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
31 Adusumilli NC, Zhang D, Friedman JM, Friedman AJ. Harnessing nitric oxide for preventing, limiting and treating the severe pulmonary consequences of COVID-19. Nitric Oxide 2020;103:4-8. [PMID: 32681986 DOI: 10.1016/j.niox.2020.07.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 14.0] [Reference Citation Analysis]
32 Pambuccian SE. The COVID-19 pandemic: implications for the cytology laboratory. J Am Soc Cytopathol 2020;9:202-11. [PMID: 32284276 DOI: 10.1016/j.jasc.2020.03.001] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 26.0] [Reference Citation Analysis]
33 Malik P, Patel K, Akrmah M, Donthi D, Patel U, Khader SN, Asiry S. COVID-19: a Disease with a Potpourri of Histopathologic Findings-a Literature Review and Comparison to the Closely Related SARS and MERS. SN Compr Clin Med 2021;:1-28. [PMID: 34396046 DOI: 10.1007/s42399-021-01029-5] [Reference Citation Analysis]
34 Chakravarty N, Senthilnathan T, Paiola S, Gyani P, Castillo Cario S, Urena E, Jeysankar A, Jeysankar P, Ignatius Irudayam J, Natesan Subramanian S, Lavretsky H, Joshi S, Garcia G Jr, Ramaiah A, Arumugaswami V. Neurological pathophysiology of SARS-CoV-2 and pandemic potential RNA viruses: a comparative analysis. FEBS Lett 2021. [PMID: 34757622 DOI: 10.1002/1873-3468.14227] [Reference Citation Analysis]
35 Dzieciatkowski T, Szarpak L, Filipiak KJ, Jaguszewski M, Ladny JR, Smereka J. COVID-19 challenge for modern medicine. Cardiol J 2020;27:175-83. [PMID: 32286679 DOI: 10.5603/CJ.a2020.0055] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
36 Liu J, Zheng X, Tong Q, Li W, Wang B, Sutter K, Trilling M, Lu M, Dittmer U, Yang D. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. J Med Virol. 2020;92:491-494. [PMID: 32056249 DOI: 10.1002/jmv.25709] [Cited by in Crossref: 267] [Cited by in F6Publishing: 264] [Article Influence: 133.5] [Reference Citation Analysis]
37 Jena S, Munusami P, Mm B, Chanda K. Computationally approached inhibition potential of Tinospora cordifolia towards COVID-19 targets. Virusdisease 2021;:1-13. [PMID: 33778129 DOI: 10.1007/s13337-021-00666-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
38 Zhou H, Larkin PMK, Zhao D, Ma Q, Yao Y, Wu X, Wang J, Zhou X, Li Y, Wang G, Feng M, Wu L, Chen J, Zhou C, Hua X, Zhou J, Yang S, Yu Y. Clinical Impact of Metagenomic Next-Generation Sequencing of Bronchoalveolar Lavage in the Diagnosis and Management of Pneumonia: A Multicenter Prospective Observational Study. J Mol Diagn 2021:S1525-1578(21)00178-1. [PMID: 34197923 DOI: 10.1016/j.jmoldx.2021.06.007] [Reference Citation Analysis]
39 Chang HC, Liu SF, Li YC, Kuo HC, Tsai YC, Chen MH. The Effectiveness of Influenza Vaccination on Chronic Obstructive Pulmonary Disease with Different Severities of Airflow Obstruction. Biomedicines 2021;9:1175. [PMID: 34572361 DOI: 10.3390/biomedicines9091175] [Reference Citation Analysis]
40 Alfsen GC, Gulczyński J, Kholová I, Latten B, Martinez J, Metzger M, Michaud K, Pontinha CM, Rakislova N, Rotman S, Varga Z, Wassilew K, Zinserling V; Working group Autopsy Pathology, European Society of Pathology. Code of practice for medical autopsies: a minimum standard position paper for pathology departments performing medical (hospital) autopsies in adults. Virchows Arch 2021. [PMID: 34888730 DOI: 10.1007/s00428-021-03242-y] [Reference Citation Analysis]
41 Vermund SH, Pitzer VE. Asymptomatic Transmission and the Infection Fatality Risk for COVID-19: Implications for School Reopening. Clin Infect Dis 2021;72:1493-6. [PMID: 32584967 DOI: 10.1093/cid/ciaa855] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 27.0] [Reference Citation Analysis]
42 Zhu D, Xu J, Chen H, Wang S, Yu L. Progressive Renal Impairment in an Older Patient with Coronavirus Disease 2019: A Case Report and Literature Review. AIDS Res Hum Retroviruses 2021;37:292-6. [PMID: 32689813 DOI: 10.1089/AID.2020.0114] [Reference Citation Analysis]
43 Masood N, Malik SS, Raja MN, Mubarik S, Yu C. Unraveling the Epidemiology, Geographical Distribution, and Genomic Evolution of Potentially Lethal Coronaviruses (SARS, MERS, and SARS CoV-2). Front Cell Infect Microbiol 2020;10:499. [PMID: 32974224 DOI: 10.3389/fcimb.2020.00499] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
44 Ayola-Serrano NC, Roy N, Fathah Z, Anwar MM, Singh B, Ammar N, Sah R, Elba A, Utt RS, Pecho-Silva S, Rodriguez-Morales AJ, Dhama K, Quraishi S. The role of 5-lipoxygenase in the pathophysiology of COVID-19 and its therapeutic implications. Inflamm Res 2021;70:877-89. [PMID: 34086061 DOI: 10.1007/s00011-021-01473-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Lancaster EC, Lee J. Potential Environmental and Health Risk when Returning to Normal Amidst COVID-19 Vaccination. Current Opinion in Environmental Science & Health 2022. [DOI: 10.1016/j.coesh.2022.100328] [Reference Citation Analysis]
46 Filardo S, Di Pietro M, Mastromarino P, Sessa R. Therapeutic potential of resveratrol against emerging respiratory viral infections. Pharmacol Ther 2020;214:107613. [PMID: 32562826 DOI: 10.1016/j.pharmthera.2020.107613] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 15.5] [Reference Citation Analysis]
47 Bhardwaj SK, Singh H, Deep A, Khatri M, Bhaumik J, Kim KH, Bhardwaj N. UVC-based photoinactivation as an efficient tool to control the transmission of coronaviruses. Sci Total Environ 2021;792:148548. [PMID: 34465056 DOI: 10.1016/j.scitotenv.2021.148548] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]